# DNA SCRIPT SERIES C CVT PFD STOCK PP

DNA SCRIPT SERIES C CVT PFD STOCK PP is a security (CUSIP TC3XW4UW2) tracked across SEC portfolio filings. 3 registered fund positions totaling $2.7M via N-PORT as of 2026-03-31.

## Summary

- Issuer: DNA SCRIPT SERIES C CVT PFD STOCK PP
- CUSIP: TC3XW4UW2
- Asset category: EP
- 13F holders: 0
- N-PORT fund positions: 3
- N-PORT value: $2.7M
- N-PORT report: 2026-03-31

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [T. Rowe Price Health Sciences Fund, Inc.](https://search.stillhousedata.com/fund/S000002088) | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $2.6M | 2.40% |
| [T. Rowe Price Health Sciences Portfolio](https://search.stillhousedata.com/fund/S000002083) | T. ROWE PRICE EQUITY SERIES, INC. | $117K | 1.77% |
| [T. Rowe Price Multi-Strategy Total Return Fund](https://search.stillhousedata.com/fund/S000058608) | T. ROWE PRICE MULTI-STRATEGY TOTAL RETURN FUND, INC. | $1K | 0.05% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/TC3XW4UW2.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.